4.6 Article

Synthetic poly(ethylene glycol)-based microfluidic islet encapsulation reduces graft volume for delivery to highly vascularized and retrievable transplant site

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites

Jessica D. Weaver et al.

SCIENCE ADVANCES (2017)

Article Instruments & Instrumentation

Engineered VEGF-releasing PEG-MAL hydrogel for pancreatic islet vascularization

Edward A. Phelps et al.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2015)

Review Pharmacology & Pharmacy

Encapsulated islets for diabetes therapy: History, current progress, and critical issues requiring solution

David W. Scharp et al.

ADVANCED DRUG DELIVERY REVIEWS (2014)

Article Multidisciplinary Sciences

Estimating the Cost of Type 1 Diabetes in the US: A Propensity Score Matching Method

Betty Tao et al.

PLOS ONE (2010)

Article Endocrinology & Metabolism

Safety and Viability of Microencapsulated Human Islets Transplanted Into Diabetic Humans

Bernard E. Tuch et al.

DIABETES CARE (2009)

Article Medicine, Research & Experimental

Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation

Robert B. Elliott et al.

XENOTRANSPLANTATION (2007)

Article Critical Care Medicine

Innate immune response in Th1- and Th2-dominant mouse strains

H Watanabe et al.

SHOCK (2004)

Article Biochemistry & Molecular Biology

Cell encapsulation: Promise and progress

Gorka Orive et al.

NATURE MEDICINE (2003)